Download Integrated Therapeutics Lab II

Howard University
College of Pharmacy
Department of Clinical and Administrative Sciences
Course Plan
Integrated Therapeutics Lab II (87763-338) 4 credit hours
Fall 2013
Course Coordinator: Salome B. Weaver, Pharm.D.
Sequence: Fall Semester
Year: 3rd Academic/Professional Year
Format: 4-Credit course
Faculty: Faculty and Guest Lecturers (Adjunct Faculty)
Prerequisite(s): All Integrated Therapeutics I courses
Office Hours/Location
Fall 2012: Wednesday
2 p.m. – 4:00 p.m. and by appointment
Annex 3, Room 121
(202) 806-7262
[email protected]
Lab Meeting Times and Places
Large Group: Monday 10:00 am – 1:00 pm in Room 3210 College of Medicine
Small Groups: Tuesday, Thursday - 11:30 a.m. - 1:00 p.m. in assigned HSL/PBL rooms
Friday – 10:00 a.m.-1:00 p.m.*
*( Fridays are reserved for special activities including but not limited to remediation activities.)
Required Textbooks:
Pharmacotherapy: principles and practice, 8th edition
Editors: Chisholm-Burns, Schwinghammer, Wells, Malone, Kolesar, DiPiro
Publishers: McGraw-Hill
ISBN: 978-0-07-162180-9
Applied Therapeutics: The Clinical Use of Drugs, 11th Edition
Editors: Koda-Kimble, Young, Alldredge, Corelli, Guglielmo, Kradjan, Williams
Publishers: Lippincott, Williams & Wilkins, Philadelphia, PA 19106
ISBN: 978-0-7817-6555-8
Drug Information Handbook, 19th Edition
Authors: Lacy, Armstrong, Goldman, Lance
Publishers: APhA Publications, Washington, DC LexiComp
ISBN# 978-1-59195-278-7
Required Study Aid:
Sigler’s Pharmacy Drug Cards
Recommended references, books, study aids:
1

Remington The Science and Practice of Pharmacy 21st edition
Editors: Beringer, DerMarderosian, Felton, Gelone, Gennaro, Gupta, Hoover,
Popovich, Reilly and Hendrickson
Publisher: Lippincott Williams & Wilkins
ISBN#: 0-78717-4673-6

Supplemental readings (journals, newsletters, websites, etc.) as assigned by
individual instructors and Course Coordinator.
Course Description
The Integrated Therapeutics (IT) Lab II is an infectious disease, hematology and
oncology modular formatted course. During IT Lab II, the student is expected to acquire
the knowledge and skills which are required to appropriately dispense and recommend
prescription, OTC, complementary and alternative medicines (CAM), medical devices
and other health care products. The appropriate selection, rational use, therapeutic
efficacy and issues, warnings, precautions, contraindications, drug interactions, use in
pregnancy and lactation of prescription medications, and use of non-prescription
medications, complementary/alternative products and home and health aids in patients
who have infectious or hematological and oncologic diseases will be studied. With
consideration given to matters of health literacy the student is expected to demonstrate
cultural competency in the development of patient-centered care and patient consultation
skills. In addition, the module will provide the student with opportunities for increasing
his or her problem-solving skills through the use of a modified problem-based learning
approach. The student is expected to attend the large group session each week and one
small group session each week. Remediation activities will be scheduled according to the
needs of the student. The student is required to review Sigler’s Pharmacy Drug Cards as
appropriate to each topic. Writing is an essential tool for thinking and communicating in
virtually every profession. Therefore, in this course I will expect you to produce writing
that is not only thoughtful and accurate, but also organized, clear, and consistent with the
rules of Standard English. If your writing does not meet these standards, I may deduct
points or ask you to revise. For assistance with your writing, go to the student section of
the
Writing
across
the
Curriculum
(WAC)
website
http://www.cetla.howard.edu/wac/students.aspx .
Course Learning Goals
The course is intended to enable the student to:
1.
2.
3.
4.
Apply the knowledge of both basic and clinical sciences in the management of
pharmaceutical care problems
Gather and organize patient information in order to identify ongoing or potential
drug-related problems and the root causes of the problems.
Interpret and evaluate pharmaceutical data and related information needed to
prevent or resolve medication-related problems.
Formulate, implement, and modify pharmaceutical care plans, including the
recommendation of pharmacotherapy specific to patient needs and desired
outcomes.
2
5.
6.
7.
8.
Display the attitudes, behavior and values required to render pharmaceutical
[patient-centered] care.
Demonstrate sensitivity to and facility with personal values and ethical principles
in professional and social contexts.
Demonstrate a basic understanding of the strengths and problems of cultural
diversity and the historic responses of society, as they related to oneself and to
others.
Demonstrate effective interpersonal and intergroup behavior in a variety of
situations and circumstances.
Course Objectives:
At the end of the course, the student shall have acquired competencies in the selection of
prescription, OTC, CAM products and home and health care products used in the
treatment of infectious and hematological /oncological diseases and in the advisement
and counseling of patients on the proper use of the medications and products. The student
shall demonstrate the following competencies;
1. Classify prescription medications used in the treatment of infectious, hematological
and oncological diseases according to therapeutic uses.
2. Identify and discuss appropriate use of home care products and devices used in the
treatment of infectious and hematological /oncological diseases.
4. Utilize an algorithm formatted process to determine the appropriateness of selftreatment versus triage for further medical evaluation in infected patients.
5. Properly advise health professionals on appropriate use, potential hazards or misuse of
prescription, potential drug-drug, drug-food and drug- laboratory result interactions of
antimicrobial and hematologic/oncologic agents.
6. Appropriately counsel patients on the proper use and handling of OTC medications and
their contraindications with concurrent use of prescription drugs and dietary
supplements in presence of infectious and hematologic/oncologic diseases. Emphasis
will be placed on matters of health literacy while recognizing patients’ healing
traditions and beliefs.
7. Identify an antimicrobial, hematological /oncological drug or product ingredient by its
trade, generic or common name, identify the therapeutic use or pharmacological
rationale for its use, and identify the known or postulated mechanism(s) of action.
8. Demonstrate the ability to verify the appropriateness of a medication regimen with
respect to the presence of infectious disease(s), hematological /oncological and comorbidities.
9. Describe proper labeling (including auxiliary/cautionary) of prescription, OTC, CAM
and home-care antimicrobial and hematological /oncological medications and
products.
10. Identify, interpret or evaluate sources of drug information for use in answering
questions regarding prescription products. Emphasis will be placed on matters of
patient health literacy and critically appraising literature on health disparities.
11. Describe proper aseptic techniques and sterilization procedures for preparing sterile
antimicrobial and hematological /oncological products.
3
12. Determine appropriate dosage, preparation, compatibilities and incompatibilities,
storage, handling, transport and administration of antimicrobial and hematological
/oncological products.
13. Recognize prescription products which may alter the therapeutic effect(s) of
antimicrobial and hematological /oncological agents.
14. Explain contemporary infectious disease and hematological /oncological public
health issues to other health professionals and patients in relationship to the treatment
of diseases and medical or physiologic conditions with respect to health literacy
status.
15. Advise/counsel patients and health care professionals on the appropriate use
of antimicrobial and hematological/oncologic medications during pregnancy and
lactation.
16. Display attitudes, behaviors and values required to render pharmaceutical care
17. Demonstrate sensitivity to personal values and ethical principles in professional and
social contexts and value the historical impact of racism among various minority cultures.
18. Demonstrate a basic understanding of the strengths and problems of cultural diversity
and the historic responses of society, as they relate to oneself and to others and be able to
list ways to enhance patient adherence
RELEVANT ACPE ACCREDITATION STANDARDS & GUIDELINES ON
CULTURAL COMPETENCY
ACPEa
ACPE Guideline 9.1
Ensuring that the curriculum
addresses patient safety, cultural
appreciation, health literacy, health
care disparities, and competencies
needed to work as a member of an
inter-professional team.
a Accreditation Council for Pharmacy Education
RELATED COURSE
OBJECTIVES
Course Objective 6, 10,
14, 16, 17 and 18
Course learning goal 5, 6,
7 and 8
RELATED TACCTb,c
DOMAIN
Objective 6 – K2(II)
Objective 10 – S1(IV)
Objective 14 - S1(III)
Objective 16 – A1 (V)
Objective 17 – A2 (IV)
Objective 18 – K6 (V)
bTool for Assessing Cultural Competence Training
cK
- Knowledge, A - Attitudes, S - Skill
Activities in the Course related to the TACCT Domain
Objective 6 – K2(II) – Recognize patient’s healing traditions and beliefs (Objective
Structured Clinical Examination Practice Session)
Objective 10 – S1(IV) – Critically Appraise literature on disparities (Journal Article
Review)
Objective 14 - S1(III) - Demonstrate strategies to address/reduce bias ( Problem Based
Learning Cases for the Small Group)
Objective 16 – A1(V) – Respect patient’s cultural beliefs (OSCE, Health Literacy
Educational Toolkit)
Objective 17 – A2 (IV) – Value the historical impact of racism (Health Literacy Lecture
and Toolkits)
4
Objective 18 – K6 (V) – List ways to enhance patient adherence (Objective Structured
Clinical Examination, Patient Counseling competition, Clinical Skills Competition and
Case Studies)
Relationship to NAPLEX Competencies (Revised)
Upon completion of the course, the student should be able to fulfill the following
NAPLEX competency areas:
Area 1 Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic
Outcomes
1.1.0 Obtain, interpret and evaluate patient information to determine the presence of a
disease or medical condition, assess the need for treatment and/or referral, and identify
patient-specific factors that affect health, pharmacotherapy, and/or disease management.
1.1.1 Identify and assess patient information including medication, laboratory and
disease state histories.
1.1.2 Identify and/or use instruments and techniques related to patient assessment and
diagnosis.
1.1.3 Identify and define the terminology, signs, and symptoms associated with
diseases and medical conditions.
1.1.4 Identify and evaluate patient factors, genetic factors, biosocial factors, and
concurrent drug therapy that are relevant to the maintenance of wellness and the
prevention or treatment of a disease or medical condition.
1.2.0. Identify, evaluate, and communicate to the patient or health-care provider, the
appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens,
dosage forms, routes of administration, and delivery systems.
1.2.1. Identify specific uses and indications for drug products.
1.2.2. Identify the known or postulated sites and mechanisms of action of
pharmacotherapeutic agents.
1.2.3. Evaluate drug therapy for the presence of pharmacotherapeutic duplications and
interactions with other drugs, food, diagnostic tests, and monitoring procedures.
1.2.4. Identify contraindications, warnings and precautions associated with a drug
product’s active and inactive ingredients.
1.2.6. Interpret and apply pharmacodynamic and pharmacokinetic principles to calculate
and determine appropriate drug dosing regimens.
1.3.0 Manage the drug regimen by monitoring and assessing the patient and/or patient
information, collaborating with other health care professionals, and providing patient
education.
1.3.1. Identify pharmacotherapeutic outcomes and endpoints.
1.3.2. Evaluate patient signs and symptoms, and the results of monitoring tests and
procedures to determine the safety and effectiveness of pharmacotherapy.
1.3.3. Identify, describe the mechanism of, and remedy adverse reactions, allergies, side
effects and iatrogenic or drug-induced illness.
1.3.4. Prevent, recognize, and remedy medication non-adherence, misuse or abuse.
1.3.5. Recommend pharmacotherapeutic alternatives.
5
Area 2 Assure Safe and Accurate Preparation and Dispensing of Medications
2.1.0 Perform calculations required to compound, dispense, and administer medication.
2.1.3 Calculate the rate of drug administration
2.2.0 Select and dispense medications in a manner that promotes safe and effective use.
2.2.1 Identify drug products by their generic, brand and/or common names.
2.2.2. Determine whether a particular drug dosage strength or dosage form is
commercially available, and whether it is available on a nonprescription basis.
Area 3 Provide Health Care Information and Promote Public Health
3.1.0 Access, evaluate and apply information to promote optimal health care.
3.1.2 Evaluate the suitability, accuracy, and reliability of information from reference
sources by explaining and evaluating the adequacy of experimental design and by
applying and evaluating statistical tests and parameters.
3.2 Educate the public and health-care professionals regarding medical conditions,
wellness, and dietary supplements, and medical devices.
3.2.1 Provide health care information regarding the prevention and treatment of
diseases medical conditions, including emergency patient care.
HUCOP Program Outcomes
11. Provide Patient-Centered Care: Through the ability to design, implement, monitor,
evaluate, and adjust pharmacy care plans that are patient-specific; address health literacy,
cultural diversity, and behavioral psychosocial issues; and are evidence-based; function
effectively as a member of an interprofessional care team; manage a successful patientcentered practice (including establishing, marketing, and being compensated for medication
therapy management and patient care services rendered).
11.1 Gather and organize patient information in order to identify ongoing or potential drugrelated problems and the root cause of the problems.
11.2 Interpret and evaluate pharmaceutical data and related information needed to prevent or
resolve medication-related problem.
11.3 Plan and perform ongoing patient evaluation to identify additional drug-related
problems.
11.4 Formulate, implement and modify pharmaceutical care plans, including the
recommendation of pharmacotherapy specific to patient needs and desired outcome.
11.5 Retrieve, evaluate, and interpret health science literature efficiently and accurately for
pharmaceutical care, research, and education.
11.6 Communicate effectively with health-care professionals and patients to ensure the
provision of safe and effective pharmaceutical care.
11.7 Integrate cultural, sociological, behavioral, economic and environmental aspects of
patient care into professional practice.
6
11.8 Prepare, dispense, and administer medications to promote safe and effective medication
use
11.9 Document pharmaceutical care activities in the patient's medical record to facilitate
communication and collaboration among providers.
11.10. Display the attitudes, behavior and values required to render pharmaceutical care.
11.11. Interpret and comply with pharmacy laws and drug regulations.
11.12. Demonstrate appropriate professional and ethical judgment in the provision of
pharmaceutical care services.
11.13 Maintain professional competence by identifying and analyzing emerging issues,
products, and services that may impact patient-specific therapeutic outcomes.
Course Activities
Course Instructors: This course is team-taught. Invited lecturers may represent a variety
of area institutions and practices. The student is expected to present with a professional
demeanor in all classroom and small group sessions.
Reading Assignments: The student is expected to review assigned reading materials and
supplemental articles provided by the instructor(s)/moderators(s) prior to the start of the
scheduled lecture or series of lectures or small group sessions.
Class Participation: The student is expected to participate in all activities and is held
responsible for course material, even when absent.
Objective Structured Clinical Examination (OSCE): There are 2 Evaluation OSCEs at
the middle and end of the semester which are worth 50 points each. A student with an
excused absence is only allowed to miss the first evaluation OSCE during the course of
the module. If an excuse is not granted, the score for the missed OSCE will be zero.
The Small Group Session provides opportunities for the student to review and/or apply
information relevant to the lecture or lecture series. Case histories, study questions or
other needed materials will be provided. Specific instructions will also be provided
regarding the manner in which the session(s) will be conducted. Please follow these
instructions carefully. The lecturer/moderator has ultimate responsibility for the content
of the learning exercises. The student has the ultimate responsibility to understand and
learn the material. The session will make use of the small group format to assure maximal
student participation. The student is assigned to a small group and is expected to attend
one small group session each week. Active participation is required. The student who is
absent from the small group session is required to contact the instructor/moderator and
course coordinator as soon as possible and make the absence known. The student will
receive no credit (i.e. 0 points) for each unexcused absence from the small group session.
Furthermore, the student who fails to report as assigned to the small group session on the
scheduled date and time shall earn the grade of "zero" unless their absence is considered
7
“excused”. An absence from a small group session shall be considered "excused" when
the student is allowed to complete a makeup assignment. In addition an absence is
considered as “excused” if it occurs because of any one of the following circumstances:
(a)
Hospitalization
of
the
student
due
to
illness
or
accident.
(b) Death in the student’s immediate family (e.g. spouse, parents, guardians, siblings
and/or children).
(c) Summons of the student to appear for jury duty or before a court of law.
In these cases, the absentee student shall submit documents supporting the above
claims (hospital admission form, death certificate or government/ court subpoena)
to the course coordinator. Upon satisfactory verification, the student shall be allowed
to complete a makeup assignment. The content of makeup assignment will be
determined by the small group session moderator.
If the student is absent from the large or small group session for a reason known prior to
the session, but fails to contact the coordinator to discuss the potential excused absence,
no excuse will be accepted and no credit will be awarded for that session’s activities and
the grade will be recorded as zero (“0”).
Assessment and Grading Policies
Module II
Evaluation/Final Grade Explanation
The final course grade will be determined as follows:
Small Group Participation (15 @ 10 pts)
Special Projects/Small Groups Assignments (15 @10 points)
Patient Counseling Assessment
OSCE 1
Clinical Skills Assessment
OSCE 2
Total =
150 points
150 points
50 points
50 points
50 points
50 points
500 points
The numerical equivalent of letter grades is as follows:
A
=
90-100%
B+
=
86-89%
B
=
80-85%
C+
=
76-79%
C
=
70-75%
F
=
<70%
Please Note: The lowest passing grade is 70% (C).
Should a student have a concern about a grade earned from an activity, he/she should
make an appointment to speak with the appropriate conference moderator/lecturer. If
adjustment is merited, the lecturer will communicate the change to the coordinator. The
student has one week following the release of a grade to make an appeal. If, after good
faith attempts have been made, the student is unable to contact the appropriate
8
moderator/lecturer during this one-week period, the student may address the matter(s)
with the course coordinator.
Exam Review
Students are allowed to view their first OSCE video in the College of Pharmacy
Computer Lab a week after the first OSCE is complete and uploaded for purposes of
improving their second OSCE.
Remediation
The course coordinator will monitor student performance and identify the student who is
experiencing academic difficulty. Remediation in this course means: students will have
attended at least 13 out of 15 of all small group sessions before they can qualify for
remediation with an excused absence for the other two missed sessions. The remediation
option includes a corrective small group assignment given by the Course faculty. Course
faculty will determine whether student deficiencies at the end of the course can be
currently remediated or if the student would best benefit by repeating the course module.
This assessment shall be undertaken in accordance with College of Pharmacy academic
policy. No remediation will be given after the end of the final OSCE for the course. There
will be no makeup if a student misses an assessment in the small/large group session
(Patient Counseling Assessment, Clinical Skills Assessment and OSCE 2)
Dress Code/Professionalism
The student is expected to demonstrate professional attitudes in dress and demeanor at all
times. The student is expected to attend all small group session dressed in a clean white
lab coat. The student is referred to the HU College of Pharmacy for more specific
information about the student dress code. *
Policy Regarding Cheating
For information regarding cheating the student is referred to the “Academic Code of
Conduct” which is published in the “H-Book “and the “Howard University Student
Reference Manual and Directory of Classes”. The pharmacy student is a professional
student, demonstration of the highest levels of honor and integrity is expected.
2. Policy Regarding Audio or Video Recordings
Neither audio nor video recording of a lecture is allowed without the expressed consent
of the lecturer.
3. Class Attendance:
i. The student is expected to attend all class sessions consistently and promptly.
ii. The student is expected to attend all small group class sessions dressed in a clean white
lab coat.
iii. The student who refrains from attending class and lab sessions is held responsible for
all course work.
iv. The student will refrain from consuming food and drinks during class sessions.
9
The Non-Registered Student
A non-registered student is not authorized nor permitted to continue in the Integrated
Therapeutics Lab II course past the final day for registration as indicated by the
University. No exceptions are permitted. A student whose name does not appear on the
official University course roster will not be allowed to remain in the class or participate
in any class activity. If the student has registered for the course and paid appropriate fees
but is not on the class roll, the student may show the instructor/moderator/coordinator an
official receipt and may be allowed to temporarily remain in class while registration
procedure is in progress. A registration printout is not acceptable as proof of registration.
HOWARD UNIVERSITY STATEMENT ON ADA PROCEDURES
Howard University is committed to providing an educational environment that is
accessible to all students. In accordance with this policy, students in need of
accommodations due to disability should contact the Office of the Dean for special
Student Services for verification and determination of reasonable accommodations as
soon as possible after admission to the University or at the beginning of each semester.
The Dean of the Office of Special Student Services, can be reached at (202) 238 2420.
Withdrawal Date
The deadline for course withdrawal is five business days prior to the scheduled final
examination or according to the University calendar.
Course Grade Posting/Course Information
Information about grades and the course will be posted on Blackboard when access is
made available to the course coordinator. Information about grades may be obtained by
contacting the course coordinator if access to Blackboard is not available and general
information about the course will be sent via email to at least one class officer. The class
officer(s) is(are) expected to forward/share the information with each student who is
enrolled in the course. If the student finds difficulty in receiving information about the
course, they should contact the course coordinator immediately.
Activity Content Inquiries
Inquiries about specific activities must be addressed with the course coordinator no later
than one week after posting of grades. The coordinator will determine when credit
should be awarded.
10
Integrated Therapeutics Lab II
87763-338
Lecture/PBL Schedule
Fall 2013
Salome Weaver, Pharm.D. Course Coordinator
August 26, 2013 through December 5, 2013
Mon 10:00 am – 1:00 pm; large group MED-3210 and
Tues or Thurs 11:30am-1:00 pm in small groups Louis B. Stokes HSL PBL Rooms
**Wednesday 12:30- 2:00 pm Large Group Remediation Activities**
**Friday 10:00 am -1:00 pm Small Group Remediation Activities**
Tuesday: Small Groups 1, 2, 3, 4, 5, and 6
Thursday: Small Groups 7, 8, 9, 10, 11 and 12
Date
Topic
M 8/26
Course Introduction Pharmaceutical Care Plans/
Health Literacy
Instructor(s)/
Moderator(s)
Weaver
Weaver
T 8/27
Th 8/29
M 9/2
Health Literacy
Weaver
Labor Day Holiday
No Class
T 9/3
Th 9/5
General Principles of Antimicrobial Therapy
Empiric vs Definitive Dosage Regimen
MIC Interpretation
Park
M 9/9
CDC-12 step to prevent antimicrobial resistance
Park
T 9/10
Th 9/12
Laboratory Monitoring Exercise
(Identify the different types of infection control methods –
CDC.gov)
Infection Control
Antimicrobial Clinical Trial Review and Journal Critique
and PK and PD Dosing
Antimicrobial Clinical Trial Review/Journal Review
PK/PD/AUC and Aminoglycosides and Quinolones
bring 2cycle semilog paper and IDSA Vancomycin
Guidelines
Park
M 9/16
T 9/17
Th 9/19
M 9/23
T 9/24
Th 9/26
M 9/30
T 10/1
Th 10/3
Multicultural Aspects of Self-Care
Nonprescription Pharmacotherapy, Pt. Assessment &
Consultation
Legal & Regulatory Issues in Self-Care Pharmacy Practice
Cases Studies in Treatment of Lower Respiratory Tract
Infections
OSCE Orientation and Demonstration
College of Medicine Clinical Skills Center and COM
3210
Patient Counseling Assessment
College of Medicine Clinical Skills Center
11
Park
Park
Mims
Park
Weaver
Weaver
M 10/7
Medications used to treat STDs and HIV
Daftary
T 10/8
Th 10/10
Medications used to treat STDs and HIV
Daftary
M 10/14
Columbus Day Holiday—No Class
T 10/15
Th 10/17
*OSCE #1 Format (Evaluation OSCE)
Groups #1 and #2
M 10/21
Antivirals, Antifungals and
Tuberculosis: 10:00 – 11:30 AM
Emergency Preparedness: 11:30 – 1:00 pm
Antivirals
Antifungals
Tuberculosis
T 10/22
Th 10/24
Weaver
Residents
**Faculty**
Daftary
Cephas
Daftary
M 10/28
Medications Used to Treat Skin and Soft Tissue Infections
Medications used to Treat UTIs
Medications used to Treat Central Nervous System
Infections
Parasites
Daftary
T 10/29
Th 10/31
Medications Used to Treat Skin and Soft Tissue Infections
Medications used to Treat UTIs
Medications used to Treat Central Nervous System
Infections
Parasites
Daftary
M 11/4
Clinical Skills Assessment
College of Pharmacy PBL Rooms, 2 nd Floor and
Multipurpose Dispensing Lab, 1st Floor
Date
Topic
T 11/5
Th 11/7
Case Studies: Medications/Therapies Used in the
Treatment of
CML, CLL, AML, ALL,
M 11/11
T 11/12
Th 11/14
No class – Veteran’s Holiday
Cancer Chemotherapy Orders
Weaver/
Residents
**Faculty**
Instructor(s)/
Moderator(s)
Moore
Lombardo
Lombardo/
Weaver
M 11/18
Supportive Care and Febrile Neutropenia
Moore
T 11/19
Th 11/21
Chemotherapy Pain Orders
Parth
M 11/25
Deficiency Anemia, Relative and Hemolytic lecture
Curry
T 11/26
Orals: The Treatment of Anemia
Moore
Lombardo
12
All small groups meet on Tues. 11/26/13
Weaver
Curry
Note: Thursday, November 28, 2013 Thanksgiving Day
Holiday- No Class
M 12/2
Supportive Care and Febrile Neutropenia
Course Evaluation
Moore
T 12/3
Th 12/5
**OSCE #2 Format (Evaluation OSCE)
Groups #1 and #2
Start time 9:00 am** Clinical Skills Center
College of Medicine Second floor
Weaver
sbw 5/30/13
Note that revisions in this schedule may be necessary and will be announced as soon as possible.
13
**Faculty**